Click here to go to the previous page
Meeting Industry Needs and 'Access' Criteria in Developing Drugs for Neglected Diseases
Program Code:
GLO080
Date:
Tuesday, May 8, 2007
Time:
11:00 AM to 12:30 PM
CHAIR
:
James Geraghty, Senior Vice President, Genzyme Cardiovascular, Genzyme Corporation
SPEAKER
(S):
James C. Greenwood, President & CEO, BIO
John P. Howe, III, President & CEO, Project Hope
Description
A range of new opportunities for industry involvement in developing drugs for neglected diseases have arisen in recent years. Support from philanthropic organizations, public-private product development partnerships and market-based mechanisms have removed financial barriers to such work.
Objectives:
Review the availability of funding sources.
Discuss the "access" criteria that are important to funding sources.
Help management teams, investors and others find ways to do work that many have long aspired to do.